The approach for assessing hospital penalties under the Hospital-Acquired Condition Reduction Program might need to be reconsidered in order to achieve the intended goal of the program.
approach for assessing hospital penalties under the
Hospital-Acquired Condition (HAC) Reduction Program might need to be reconsidered in order to achieve the intended goal of the program, according to findings published in JAMA.
relationship between the hospital quality summary score and HAC program penalization as well as publicly reported process-of-care and outcome measures from 4 clinical areas: surgery, acute myocardial infarction, heart failure, and pneumonia.
The findings of the study showed hospitals were more likely to be penalized if they had accreditations, offered advanced services, were major teaching institutions or performed better on other quality measures.
reduces payments to the lowest-performing hospitals, and researchers examined the
The HAC Reduction Program
The
“Higher-performing hospitals were penalized more because some of the measures that CMS uses to assess quality are flawed,” senior author Karl Bilimoria, MD, assistant professor in surgery-surgical oncology and director of the Surgical Outcomes and Quality Improvement Center, said in a statement. “The measures paradoxically identify high-performing hospitals as poor performers. Clearly this is not ideal for hospitals or for patients.”
ospitals with the highest quality score of 8 were penalized significantly more frequently than hospitals with the lowest quality score of 0.
Nearly one-fourth (22%) of participating hospitals were penalized and h
See the study: http://bit.ly/1PfhkJH
The Supreme Court seems likely to reject a challenge to the abortion pill mifepristone; the FDA is inspecting far fewer pharmaceutical companies conducting clinical research; AstraZeneca has sued to block an Arkansas law that it said would unlawfully expand the 340B program to include for profit-pharmacy chains.
Read More
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
Covered Preventive Services at Risk: V-BID Summit Breaks Down the Braidwood v Becerra Case
March 20th 2024For more than a decade, certain high-value preventive care services have been covered at no cost to patients under the Affordable Care Act, but a current legal challenge has the coverage at risk.
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Evolution of HDHPs With VBID Components Can Improve Care for Chronic Disease
March 14th 2024Over the course of the last 20 years, high-deductible health plans (HDHPs) have undergone an evolution. Today’s plans, with more high-value services covered predeductible, can improve care for people with chronic diseases, said panelists at the 2024 Value-Based Insurance Design (V-BID) Summit.
Read More
Fragmented Payer System, Vulnerable Supply Chain Among Threats to Accessing Essential Medicines
March 13th 2024During a session of the 2024 V-BID Summit, panelists Stacie Dusetzina, PhD, and Inma Hernandez, PharmD, PhD, discussed how access to essential medications is curtailed not just by the longstanding complexities of insurance design but also by emerging threats such as supply chain weaknesses and cyberattacks.
Read More